Nicolas Angell

Executive Director, Analytical and Formulation Development at Attralus Therapeutics

Nicolas Angell has worked in the pharmaceutical industry since 1990. Nicolas'swork experience includes positions at Glaxo as a Research Scientist (1990-1995), Merck as a Research Scientist (1995-2000), Pacific Northwest National Laboratory as a Postdoctoral Research Fellow (2000-2002), Human Genome Sciences or HGSI as a Senior Scientist in the Pharmaceutical Sciences, Protein Development Department (2002-2004), and Amgen as a Senior Scientist in the Analytical Sciences, Process & Analytical Sciences (2004-2021). Nicolas then moved to Connect Biopharma as an Executive Director of CMC Project Management & Strategic Alliance (2021-2022). Currently, they are an Executive Director of Analytical and Formulation Development at Attralus (2022-present).

Nicolas Angell obtained a PhD in Chemistry from Imperial College London between 1997 and 2000.

Location

Ventura, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Attralus Therapeutics

Attralus is a clinical stage biopharmaceutical company focused on creating transformative medicines to improve the lives of patients with systemic amyloidosis.


Industries

Employees

11-50

Links